Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar-Apr;36(3):426-431.
doi: 10.12669/pjms.36.3.1804.

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis

Affiliations

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis

Muhammad Haseeb Nawaz et al. Pak J Med Sci. 2020 Mar-Apr.

Abstract

Objective: To determine efficacy of diclofenac suppository in reducing post-ERCP pancreatitis (PEP) and identify risk factors for PEP.

Methods: This is a placebo-based prospective study at Department of Medicine & Gastroenterology, Services Institute of Medical Sciences / Services Hospital, Lahore performed from January 2018 to June 2019. Patients were randomized to receive diclofenac suppository or glycerine suppository before ERCP. Both groups were compared for PEP using chi square x2 test while risk factors for PEP were determined using binary logistic regression.

Results: Total of 165 patients with mean age 49.1(±15.2) and male to female ratio 1/1.6 (63/102) were included. Among 82 (49.7%) patients in diclofenac group, 8 (9.7%) developed pancreatitis while 19(22.9%) of 83(50.3%) in placebo group had PEP (p value 0.02). After multivariate analysis, age>45 years (p value 0.014, OR 3.2), Bilirubin >3 mg/dl (p value 0.004 OR 3.58), time to cannulation> 5 minutes (p value<0.000 OR 9.2), use of precut (p value< 0.000 OR 4.9), pancreatic duct cannulation (p value 0.000 OR 5.46) and total procedure time >30 minutes (p value 0.01 OR 3.92) were risk factors for PEP.

Conclusion: Pre-procedure Diclofenac suppository reduces post-ERCP pancreatitis. Age > 45 years, serum bilirubin > 3 mg/dl, cannulation time > 5 minutes, use of precut, pancreatic duct cannulation and procedure time > 30 minutes are risk factors for post-ERCP pancreatitis.

Keywords: NSAIDs; Post-ERCP pancreatitis; Primary prophylaxis; Risk factors.

PubMed Disclaimer

Figures

Fig.1
Fig.1
ROC Curve to identify best coordinate points.

References

    1. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of vater:a preliminary report. Ann Surg. 1968;167(5):752–756. doi:10.1097/00000658-196805000-00013. - PMC - PubMed
    1. Matsushita M, Koyabu M, Nishio A, Seki T, Okazaki K. Techniques of ERCP with a conventional endoscope in pancreatoduodenectomy anatomy. Gastrointest Endosc. 2017;86:747–748. doi:10.1016/j.gie.2017.05.007. - PubMed
    1. Guda NM, Freeman ML. Lee LS, editor ERCP and EUS:A Case-Based Approach. New York: Springer; 2015. Overview of ERCP Complications:Prevention and Management; pp. 37–56. doi:10.1007/978-1-4939-2320-5.
    1. Kahaleh M, Freeman M. Prevention and management of post-endoscopic retrograde cholangiopancreatography complications. Clin Endosc. 2012;45:305–312. doi:10.5946/ce.2012.45.3.305. - PMC - PubMed
    1. Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. 2017;52:1013–1022. doi:10.1007/s00535-017-1359-5. - PubMed

LinkOut - more resources